Giulia Corso, Author at Evercyte - Forever is just enough

13 08, 2024

Newly released telomerized amniotic epithelial cells

Newly released telomerized amniotic epithelial cells

By Giulia Corso|2024-09-26T11:28:18+00:00August 13th, 2024|cell line development, recent highlights cell line development, telomerized cells|

Newly released telomerized amniotic epithelial cells August 13th, 2024, Vienna, Austria We are thrilled to announce the newest addition to our

27 06, 2024

Evercyte highlights immortalized cell technology at SelectBIO Rotterdam 2024

Evercyte highlights immortalized cell technology at SelectBIO Rotterdam 2024

By Giulia Corso|2024-09-26T11:28:45+00:00June 27th, 2024|cell line development, conferences, EV cell factories, extracellular vesicles, organ-on-a-chip|

Evercyte highlights immortalized cell technology at SelectBIO Rotterdam 2024 June 27th, 2024, Vienna, Austria We participated as technology spotlight speakers at

23 05, 2024

hTERT immortalized ASC for large-scale EV production

hTERT immortalized ASC for large-scale EV production

By Giulia Corso|2024-05-29T13:40:27+00:00May 23rd, 2024|Extracellular vesicles, mesenchymal stromal cells, recent highlights EV, telomerized cells|

Recent publication showcasing our ASC/TERT1 cells as EV production system May 23rd, 2024, Vienna, AustriaOur telomerized human adipose derived MSC (ASC/TERT1, also known in

29 04, 2024

Evercyte proudly introduces the EVscale™ platform

Evercyte proudly introduces the EVscale™ platform

By Giulia Corso|2024-09-26T11:29:18+00:00April 29th, 2024|EVscale, Extracellular vesicles, recent highlights EV|

Evercyte proudly introduces the EVscale™ platform April 29th, 2024, Vienna, Austria The collaborative effort of Evercyte, Phoenestra, and TAmiRNA has yielded the EVscale™ platform,

16 02, 2024

Newly published study featuring our PODO/TERT256 cell line

Newly published study featuring our PODO/TERT256 cell line

By Giulia Corso|2024-09-26T11:49:21+00:00February 16th, 2024|PODO/TERT256, telomerized cells|

Recent publication showcasing our PODO/TERT256 telomerized cell line February 16th, 2024, Vienna, Austria Our telomerized human podocyte cells (PODO/TERT256) were employed in an

7 12, 2023

Evercyte contributing to reduce animal testing at key events

Evercyte contributing to reduce animal testing at key events

By Giulia Corso|2024-09-26T11:29:37+00:00December 7th, 2023|3Rs, cell line development, conferences, GCCP|

Evercyte contributing to reduce animal testing at key events December 7th, 2023, Vienna, Austria We participated as an invited attendee at

22 11, 2023

Evercyte Showcases Expertise in Japan’s Pharma Landscape

Evercyte Showcases Expertise in Japan’s Pharma Landscape

By Giulia Corso|2024-09-26T11:30:10+00:00November 22nd, 2023|cell line development, collaboration, EV cell factories, Extracellular Vesicles, mesenchymal stromal cells|

Evercyte Showcases Expertise in Japan’s Pharma Landscape November 22nd, 2023, Vienna, Austria We recently visited Summit Pharmaceuticals International to present our

27 10, 2023

Participation to the first MOVE symposium

Participation to the first MOVE symposium

By Giulia Corso|2024-09-26T11:30:28+00:00October 27th, 2023|Extracellular vesicles and ageing, mesenchymal stromal cells|

We participated to the first MOVE symposium in Malaga, Spain October 27th, 2023, Vienna, Austria We participated to the first MOVE

19 09, 2023

Participation to the Small New World 2.0 meeting

Participation to the Small New World 2.0 meeting

By Giulia Corso|2024-09-26T11:30:55+00:00September 19th, 2023|Extracellular vesicles and ageing, mesenchymal stromal cells|

We participated to the Small New World 2.0 meeting in Graz, Austria September 12th, 2023, Vienna, Austria We participated to the

4 08, 2023

RPTEC/TERT1 relevant kidney-on-a-chip model

RPTEC/TERT1 relevant kidney-on-a-chip model

By Giulia Corso|2023-09-19T07:33:39+00:00August 4th, 2023|3Rs, collaboration, organ-on-a-chip, RPTEC/TERT1|

Collaboration with Nortis to establish human kidney-on-a-chip model August 4th, 2023. Vienna, Austria Our telomerized Human Renal Proximal Tubular Epithelial cells (RPTEC/TERT1) were used in collaboration with

About Giulia Corso

Newly released telomerized amniotic epithelial cells

Evercyte highlights immortalized cell technology at SelectBIO Rotterdam 2024

hTERT immortalized ASC for large-scale EV production

Evercyte proudly introduces the EVscale™ platform

Newly published study featuring our PODO/TERT256 cell line

Evercyte contributing to reduce animal testing at key events

Evercyte Showcases Expertise in Japan’s Pharma Landscape

Participation to the first MOVE symposium

Participation to the Small New World 2.0 meeting

RPTEC/TERT1 relevant kidney-on-a-chip model

Title